Stocks Health care GHRS
NASDAQ · Health careGH Research PLC (GHRS)
It posted a net loss of $48.3M. In fiscal 2025 capital spending exceeded operating cash flow by $43.7M. At December 31, 2025 it held $246.3M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 5, 2026.
Key facts about GH Research PLC
- Net worth
- GH Research PLC has a market value (market cap) of $1.3B at the latest share price, and shareholders' equity of $279.7M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Cash flow
- In fiscal 2025 operations used $43.6M of cash.
- Latest report
- The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on March 5, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR
What GH Research PLC does
GH Research PLC is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker GHRS.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$48.3M | -$0.79 | -$43.7M |
| 2024 | n/a | -$39M | -$0.75 | -$42.3M |
| 2023 | n/a | -$35.6M | -$0.68 | -$33.4M |
| 2022 | n/a | -$22.5M | -$0.43 | -$26.3M |
| 2021 | n/a | -$9.2M | -$0.21 | -$15.4M |
| 2021 | n/a | -$446K | -$0.02 | -$330K |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What GH Research PLC has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026Passive stake changed SCHEDULE 13G/A
- October 9, 2026
- September 11, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 6, 2026
- June 26, 2026
- June 4, 2026
- May 21, 2026
- May 18, 2026Passive stake changed SCHEDULE 13G/A
Insider trades
What the people running GH Research PLC did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Who owns GHRS
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Lynx1 Capital Management LP13G, passive with 1 related filers | 19.3% | August 14, 2026 |
| Bvf Partners L P13G, passive with 9 related filers | 14.2% | May 15, 2025 |
| RTW Investments, LP13G, passive with 1 related filers | 8.9% | May 15, 2025 |
| Fmr LLC13G, passive with 1 related filers | 8.2% | August 6, 2025 |
| RA Capital Management, L.P.13G, passive with 3 related filers | 7.1% | August 14, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 63 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Lynx1 Capital Management LP | 13,263,288 | +2,500,000 |
| Bvf Inc | 8,650,158 | 0 |
| RA Capital Management, L.P. | 7,636,813 | -39,884 |
| Fmr LLC | 5,977,045 | +841,000 |
| Rtw Investments, LP | 5,933,815 | 0 |
| Deep Track Capital, LP | 3,333,334 | new |
| Avoro Capital Advisors LLC | 1,800,000 | 0 |
| Foresite Capital Management VI LLC | 940,493 | +625,001 |
| Jefferies Financial Group Inc. | 712,300 | 0 |
| BlackRock, Inc. | 480,287 | +24,669 |
| UBS Group AG | 477,408 | +64,992 |
| Millennium Management LLC | 323,399 | -614,499 |
| Braidwell LP | 207,240 | new |
| Boothbay Fund Management, LLC | 202,103 | -80,788 |
| Jane Street Group, LLC | 169,951 | new |
| HighVista Strategies LLC | 158,770 | -54,442 |
| Trexquant Investment LP | 153,767 | +83,959 |
| Goldman Sachs Group Inc | 148,673 | +103,878 |
| XTX Topco Ltd | 86,986 | +34,896 |
| Citadel Advisors LLC | 85,952 | +20,488 |
Insiders
Questions about GHRS
What does GH Research PLC do?
GH Research PLC is a company in the Health care sector, listed on NASDAQ as GHRS. Its shares trade on NASDAQ under the ticker GHRS.
What is GH Research PLC's net worth?
GH Research PLC has a market value (market cap) of $1.3B at the latest share price, and shareholders' equity of $279.7M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is GH Research PLC profitable?
No. In fiscal 2025 it reported a net loss of $48.3M.
When did GH Research PLC last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 5, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the passive stake changed from November 5, 2026.
Similar companies
Compare GHRS with
Follow GHRS
Get an email when GH Research PLC files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values GH Research PLC tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.